← Back to Search

Control group: Passive lecture series for Multiple Sclerosis (NIA Trial)

Phase < 1
Waitlist Available
Led By Donovan Adendorf, DC
Research Sponsored by Nelson Mandela Metropolitan University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change: baseline and 12 weeks
Awards & highlights

NIA Trial Summary

Standing Balance, with and without blindfold, will be measured on patients with Multiple Sclerosis using a Biodex Balance Scale. A Twelve week intervention with one non impact aerobics group and one control group will be performed. Standing balance will then be retested on all subjects and the results will be statistically compared.

Eligible Conditions
  • Multiple Sclerosis

NIA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change: baseline and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change: baseline and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biodex Scale Balance score: Automated
Secondary outcome measures
Pre and post intervention questionaire

NIA Trial Design

2Treatment groups
Active Control
Group I: Control group: Passive lecture seriesActive Control1 Intervention
The control group will also be measured for balance and then attend a 12 week lecture series with no exercise. They will then also be remeasured post lectures series
Group II: Active non impact aerobicsActive Control1 Intervention
This group will be performing a 12 week non impact aerobics program twice a week.

Find a Location

Who is running the clinical trial?

Nelson Mandela Metropolitan UniversityLead Sponsor
1 Previous Clinical Trials
22,464 Total Patients Enrolled
Donovan Adendorf, DCPrincipal InvestigatorNelson Mandela Metropole University, Department of Health Sciences
Rosa DuRandt, PhDStudy DirectorProfessor: Human Movement Sciences, NMMU-Port Elizabeth South Africa

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby May 2025